25 Healthcare Stocks Moving In Today's Pre-Market Session

Gainers

• DBV Technologies, Inc. DBVT stock rose 17.3% today to $10.72 during Thursday's pre-market session. The most recent rating by Goldman Sachs, on June 17, is at Buy, with a price target of $14.00.
• Evoke Pharma, Inc. EVOK shares moved upwards by 12.0% today to $1.10. The market cap seems to be at $20.4 million.
• Cronos Group, Inc. CRON stock rose 8.7% today to $15.69. According to the most recent rating by Consumer Edge, on June 28, the current rating is at Equal-Weight.
• Aptevo Therapeutics, Inc. APVO stock surged 7.5% today to $1.00. The market value of their outstanding shares is at $39.9 million.
• MannKind, Inc. MNKD stock rose 7.1% today to $1.20. The market value of their outstanding shares is at $210.3 million. The most recent rating by BTIG Research, on May 14, is at Buy, with a price target of $3.00.
• G1 Therapeutics, Inc. GTHX stock rose 5.6% today to $24.80. The market cap seems to be at $690.5 million. The most recent rating by JP Morgan, on August 08, is at Overweight, with a price target of $45.00.
• Cancer Genetics, Inc. CGIX stock increased by 5.0% today to $0.15. The market value of their outstanding shares is at $7.9 million.
• Perrigo Co, Inc. PRGO stock rose 4.0% today to $52.50. The market value of their outstanding shares is at $6.5 billion.
• AVEO Pharmaceuticals, Inc. AVEO stock rose 3.3% today to $0.68. The market cap stands at $338.4 million.
• MorphoSys, Inc. MOR stock rose 3.3% today to $31.42. The market value of their outstanding shares is at $3.7 billion.
• Verastem Oncology, Inc. VSTM shares rose 3.1% today to $1.35. The market cap stands at $373.7 million.
• HEXO, Inc. HEXO shares surged 3.0% today to $4.50. The market value of their outstanding shares is at $1.0 billion. According to the most recent rating by Oppenheimer, on June 25, the current rating is at Perform.
• Aphria, Inc. APHA shares increased by 2.9% today to $7.05. The market value of their outstanding shares is at $1.3 billion. According to the most recent rating by CIBC, on July 26, the current rating is at Underperformer.
• Sundial Growers, Inc. SNDL stock surged 2.9% today to $13.22. The market cap stands at $980.5 million.
• Aurora Cannabis, Inc. ACB shares surged 2.7% today to $6.80. The market value of their outstanding shares is at $6.4 billion. According to the most recent rating by Bank of America, on July 18, the current rating is at Neutral.
• Canopy Growth, Inc. CGC shares rose 2.6% today to $33.05. The market cap seems to be at $4.2 billion. The most recent rating by Ladenburg Thalmann, on July 17, is at Buy, with a price target of $50.00.
• Genfit, Inc. GNFT stock moved upwards by 2.2% today to $16.82. The market cap seems to be at $638.7 million.
• OPKO Health, Inc. OPK shares surged 2.0% today to $1.99. The market cap stands at $2.1 billion.

Losers

• Wright Medical Group, Inc. WMGI stock fell 21.6% today to $22.00 during Thursday's pre-market session. The market cap stands at $3.5 billion. The most recent rating by RBC Capital, on August 08, is at Sector Perform, with a price target of $24.00.
• Ocular Therapeutix, Inc. OCUL shares declined 9.6% today to $4.13. The market value of their outstanding shares is at $200.4 million. According to the most recent rating by Cowen & Co., on May 21, the current rating is at Market Perform.
• Organovo Holdings, Inc. ONVO stock declined 9.1% today to $0.26. The market cap seems to be at $52.1 million. According to the most recent rating by H.C. Wainwright, on August 08, the current rating is at Neutral.
• T2 Biosystems, Inc. TTOO shares declined 6.2% today to $0.69. The market cap seems to be at $326.0 million. The most recent rating by Alliance Global Partners, on August 01, is at Neutral, with a price target of $0.40.
• Aevi Genomic Medicine, Inc. GNMX stock fell 3.8% today to $0.23. The market cap stands at $10.3 million.
• Teva Pharmaceutical Indus, Inc. TEVA shares decreased by 2.8% today to $7.08. The market cap seems to be at $8.3 billion. The most recent rating by Morgan Stanley, on July 15, is at Underweight, with a price target of $6.00.
• Catalyst Pharmaceuticals, Inc. CPRX stock declined 2.5% today to $5.00. The market cap stands at $513.2 million.